Assistant Professor, Cardiovascular Surgery, Perelman School of Medicine
Thoracic Surgery
Dr. Pavan Atluri, MD
|
|
Give Review
Dr. Pavan Atluri practices Thoracic Surgery. He studied medicine at Albany Medical College. He has 1 awards "Fellow (FACS)". Pavan Atluri is a published doctor and has 64 publications published. The lastest was: 'Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Minimally invasive mitral Valve surgery is associated with equivalent cost and shorter hospital stay when compared with traditional sternotomy.
- Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.
- Transplantation of "high-risk" donor Hearts: Implications for infection.
- Comparison of Causes of Death After Heart Transplantation in Patients With Left Ventricular Ejection Fractions ≤35% Versus >35.
- Post-left ventricular assist device support right ventricular Failure: Can it be predicted preoperatively, and should it be a contraindication to implantation?
- Increasing Frequency of Left Ventricular Assist Device Exchanges in the United States.
- Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.
- Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular ...
- Building a better bridge: Remodeling, recovery, and a better understanding of the biologic foundation of mechanical circulatory support.
- Preclinical Models for Translational Investigations of Left Ventricular Assist Device-Associated von Willebrand Factor Degradation.
- Evaluation of late Aortic insufficiency with continuous flow left ventricular assist deviceâ€Â
- Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: Mechanical demolition and enzymatic cleavage.
- Port Access Cardiac Operations Can Be Safely Performed With Either EndoAortic Balloon or Chitwood Clamp.
- Combined Heart and liver transplantation can be safely performed with excellent short- and long-term results.
- A Bioengineered Hydrogel System Enables Targeted and Sustained IntraMyocardial Delivery of Neuregulin, Activating the Cardiomyocyte Cell Cycle and Enhancing Ventricula...
- Unexpected abrupt increase in left ventricular assist device thrombosis.
- Therapeutic potential of Rb phosphorylation in atherosclerosis.
- Preclinical Evaluation of the Engineered Stem Cell Chemokine Stromal Cell-Derived Factor 1-alpha Analogue in a Translational Ovine Myocardial Infarction Model.
- Impact of guideline implementation on transfusion practices in a surgical intensive care unit.
- Continuous flow left ventricular assist device implant significantly improves pulmonary hypertension, right ventricular contractility, and tricuspid Valve competence.
- Treatment of ventricular assist-device-associated gastrointestinal bleeding with hormonal therapy.
- Normalization of postinfarct biomechanics using a novel tissue-engineered angiogenic construct.
- Sustained Release of Engineered Stromal Cell-Derived Factor 1-α From Injectable Hydrogels Effectively Recruits Endothelial Progenitor Cells and Preserves Ventricular F...
- Spatially oriented, temporally sequential smooth muscle cell-endothelial progenitor cell bi-level cell sheet neovascularizes ischemic myocardium.
- Minimally Invasive Mitral Valve Surgery Can Be Performed With Optimal Outcomes in the Presence of Left Ventricular Dysfunction.
- Nonresectional Single-Suture Leaflet Remodeling for Degenerative Mitral Regurgitation Facilitates Minimally Invasive Mitral Valve Repair.
- Continuous-flow left ventricular assist device implantation in the presence of a hostile ventricular apex.
- Ventricular assist device implant in the elderly is associated with increased, but respectable risk: a multi-institutional study.
- Predicting Right Ventricular Failure in the Modern, Continuous Flow Left Ventricular Assist Device Era.
- Robotic and minimally invasive cardiac surgery.
- Minimally invasive approach provides at least equivalent results for surgical correction of Mitral regurgitation: A propensity-matched comparison.
- Rapid onset of fulminant myocarditis portends a favourable prognosis and the ability to bridge mechanical circulatory support to recovery.
- Mathematically engineered stromal cell-derived factor-1? stem cell cytokine analog enhances mechanical properties of infarcted myocardium.
- Diastolic ventricular support with cardiac support devices: an alternative approach to prevent adverse ventricular remodeling.
- Novel Strategy to Improve End-Organ Function With Pulsatile CardioPulmonary Bypass.
- Computational protein design to reengineer stromal cell-derived factor-1? generates an effective and translatable angiogenic polypeptide analog.
- Careful echocardiographic analysis of right ventricular function as a long-term prognostic variable in systolic Heart failure.
- The next decade in mechanical assist: advances that will help the patient and the doctor.
- Oxygen-dependent quenching of phosphorescence used to characterize improved Myocardial oxygenation resulting from vasculogenic cytokine therapy.
- Minimally invasive robotic mitral Valve surgery.
- Pulsatile left ventricular assist devices: what is the role in the modern era?
- Spliced stromal cell-derived factor-1? analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardia...
- Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after Myocardial infarction by indu...
- Acute myocardial rescue with endogenous endothelial progenitor cell therapy.
- Myocardial transfection of adeno-hypoxia inducible factor-1alpha. - A novel strategy to potentiate vasculogenesis in ischemic myocardium -.
- Progress in mitral Valve disease: understanding the revolution.
- Off-pump, minimally invasive and robotic Coronary revascularization yield improved outcomes over traditional on-pump CABG.
- Pro-angiogenic cytokines as cardiovascular therapeutics: assessing the potential.
- Cardiac retransplantation is an efficacious therapy for primary cardiac allograft Failure.
- TransMyocardial revascularization to enhance Myocardial vasculogenesis and hemodynamic function.
- Minimally invasive Aortic valve papillary fibroelastoma resection.
- High-risk repair of ascending Aortic aneurysm due to giant cell aortitis.
- Myocardial regeneration therapy for ischemic Cardiomyopathy with cyclin A2.
- Minimally invasive, robotic, and off-pump mitral Valve surgery.
- Ischemic Heart failure enhances endogenous myocardial apelin and APJ receptor expression.
- Placental growth factor provides a novel local angiogenic therapy for ischemic Cardiomyopathy.
- Prone positioning to treat Acute severe pulmonary edema in the post-cardiac surgical patient: a case report.
- Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic Heart failure.
- Neovasculogenic therapy to augment perfusion and preserve viability in ischemic Cardiomyopathy.
- Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction.
- Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic Cardiomyopathy.
- Factor V Leiden and postoperative deep vein thrombosis in patients undergoing open Roux-en-Y gastric bypass surgery.
- Active thermoregulation improves outcome of off-pump Coronary artery bypass.
Schools
Albany Medical College
Procedures Preformed
- Aortic Repair, Open or Repair of Arterial Aneurysm, Open
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
- Chest CT (incl. Heart and Lungs)
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiac Surgery
- Thoracic Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
University of Pennsylvania Health System -
Albany Medical College
Hospital
-
Hospital of the University of Pennsylvania -
Penn Presbyterian Medical Center -
Pennsylvania Hospital
Drug Facts
| NPI NUMBER | 1407913940 | |
| NPPES Provider LastName | ATLURI | |
| NPPES Provider FirstName | PAVAN | |
| NPPES Provider ZIPCode | 191044206 | |
| NPPES Provider State | PA | |
| Specialty Description | Cardiac Surgery | |
| Total Claim Count | 21.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1407913940 |
| Last Name Of The Provider | ATLURI |
| First Name Of The Provider | PAVAN |
| View All |
Similar Doctors
|
Dr. Achintya Moulick, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shinya Unai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bilal M. Shafi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yoshiya Toyoda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ibrahim Sultan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard S. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Sokol, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gurjyot Bajwa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harrison T. Pitcher, MD
This Doctor is OpenDoctor Recommended.
|